1d
Zacks.com on MSNModerna Poised to Report Q4 Earnings: Is a Beat in the Cards?We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before ...
Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.
The three winners Dr. Kiana Aran (UC San Diego, USA ), Dr. Amanda Randles ( Duke University, USA ), and Dr. Yating Wan (King ...
More than any other university in the country, Hopkins will be significantly affected by the pause on federal grants and the ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.
We had 3.5% unemployment right before COVID hit and everything fell apart ... “You know, I want to own, I want to own CRISPR ...
"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...
Robert F. Kennedy, Jr.’s recent disclosures have revealed several potential conflicts of interest, including investments in two biopharma companies.
Robert F. Kennedy Jr. is distancing himself from his anti-vaccine work as he seeks to become the leader of the nation's top health agency under President Trump, according to government ethics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results